Compare

SCOR SE/€SCR

1D1W1M3M6MYTD1Y5YMAX

About SCOR SE

SCOR SE is a global reinsurance company that provides life and property & casualty reinsurance services. Its core business segments include Life & Health reinsurance, offering solutions pertaining to life insurance, health insurance, and reinsurance of similar risks, as well as Property & Casualty reinsurance, which covers non-life products such as property, motor, and specialty lines. Founded in 1970, SCOR is headquartered in Paris, France, and operates across various international markets, serving clients globally. The company is strategically positioned to leverage its extensive actuarial expertise and diversified risk management capabilities, providing tailored reinsurance solutions that address the complex risks faced by its clients.
Ticker
€SCR
Sector
Finance
Primary listing
PAR
Employees
3,610
Headquarters
Paris, France

SCOR SE Metrics

BasicAdvanced
€6.2B
7.73
€4.48
0.52
€1.90
5.49%

What the Analysts think about SCOR SE

Analyst ratings (Buy, Hold, Sell) for SCOR SE stock.
Analyst projections of the future price of SCOR SE stock.

Bulls say / Bears say

SCOR’s third-quarter net income of €206 million beat its €176 million analyst consensus, despite falling 4.8% year on year. That points to better-than-expected earnings resilience in an active catastrophe quarter. (Reuters)
P&C underwriting remained profitable through an active catastrophe quarter: the combined ratio was 84.1% in Q3 and 81.3% for the first nine months, well below SCOR’s 87% target. The nine-month catastrophe ratio was 5.4%, within its 10% budget. (SCOR)
SCOR’s estimated solvency ratio rose six percentage points to 221%, while economic value increased 11.9% at constant economics over the first nine months. Adjusted annualised return on equity was 19.3%, giving the group a stronger capital and earnings base. (SCOR)
Quarterly earnings are still lower than a year ago: Q3 net income fell 4.8%, while the P&C insurance service result dropped 15% and its combined ratio worsened from 80.9% to 84.1%. (Reuters, SCOR)
Life & Health remains a weak spot: nine-month insurance revenue fell 6.2% year on year and its insurance service result declined 17.4%. That contraction could weigh on group growth even though the segment improved in Q3. (SCOR)
Renewal pricing is weakening and could squeeze future margins as lower prices work through the book. SCOR reported gross price declines of 4.4% overall at mid-year renewals, including 9.5% on non-proportional business, while Fitch warned that successive cuts could weigh on reinsurer earnings in coming quarters. (Artemis, Reinsurance News)
Data summarised monthly by Lightyear AI. Last updated on 30 Oct 2026.

SCOR SE Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

SCOR SE Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing SCOR SE

AllEURUSDGBP
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.